deltatrials
Completed NA INTERVENTIONAL 2-arm NCT03649178

Dietary Salt in Rheumatoid Arthritis

Inflammatory and Vascular Response to Dietary Salt in Rheumatoid Arthritis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Interventions salt
Updated 19 times since 2018 Last updated: Oct 8, 2025 Started: Jan 2, 2020 Primary completion: Sep 30, 2024 Completion: Dec 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03649178, this NA trial focuses on Rheumatoid Arthritis and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 19 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Sep 2019 · 4 months · monthly snapshot~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Nov 2020 · 8 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshot~Dec 2021 – ~Nov 2022 · 11 months · monthly snapshot~Nov 2022 – ~Nov 2023 · 12 months · monthly snapshot~Nov 2023 – ~Jun 2024 · 7 months · monthly snapshot~Jun 2024 – ~Jul 2024 · 30 days · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Mar 2025 · 3 months · monthly snapshot~Mar 2025 – ~Jun 2025 · 3 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshot~Nov 2025 – present · 8 months · monthly snapshot

Change History

19 versions recorded
  1. Nov 2025 — Present [monthly]

    Completed NA

  2. Sep 2025 — Nov 2025 [monthly]

    Completed NA

  3. Jun 2025 — Sep 2025 [monthly]

    Completed NA

  4. Mar 2025 — Jun 2025 [monthly]

    Completed NA

    Status: Active Not RecruitingCompleted

  5. Dec 2024 — Mar 2025 [monthly]

    Active Not Recruiting NA

Show 14 earlier versions
  1. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting NA

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  3. Jun 2024 — Jul 2024 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  4. Nov 2023 — Jun 2024 [monthly]

    Recruiting NA

  5. Nov 2022 — Nov 2023 [monthly]

    Recruiting NA

  6. Dec 2021 — Nov 2022 [monthly]

    Recruiting NA

  7. Jan 2021 — Dec 2021 [monthly]

    Recruiting NA

  8. Nov 2020 — Jan 2021 [monthly]

    Recruiting NA

  9. Mar 2020 — Nov 2020 [monthly]

    Recruiting NA

  10. Feb 2020 — Mar 2020 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  11. Sep 2019 — Feb 2020 [monthly]

    Not Yet Recruiting NA

  12. May 2019 — Sep 2019 [monthly]

    Not Yet Recruiting NA

  13. Feb 2019 — May 2019 [monthly]

    Not Yet Recruiting NA

  14. Sep 2018 — Feb 2019 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institutes of Health (NIH)
  • Vanderbilt University Medical Center
Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations